Schedule 13D ownership disclosure

AERIE PHARMACEUTICALS INC

Security class unavailable

Event date: 2014-05-22

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
16.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001571049-14-002198
Form type
SC 13D
Filer
ACP IV, L.P.
CIK
CIK 1282908
Filed
May 30, 2014
Reporting period
May 22, 2014
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub